Viewing Study NCT06461741



Ignite Creation Date: 2024-07-17 @ 11:52 AM
Last Modification Date: 2024-10-26 @ 3:32 PM
Study NCT ID: NCT06461741
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-06-17
First Post: 2024-06-10

Brief Title: EMG Biofeedback Training to Improve Balance in Individuals With Multiple Sclerosis
Sponsor: McMaster University
Organization: McMaster University

Study Overview

Official Title: Integrated Dual-task EMG Biofeedback Balance Training to Improve Balance in Individuals Living With Multiple Sclerosis
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: MSBAL
Brief Summary: The goal of this clinical trial is to test the impact of a novel dual-task EMG Biofeedback training method for improving balance in individuals living with multiple sclerosis The main questions it aims to answer are

Does dual-task EMG biofeedback training deliver lasting balance benefits up to 3 months following the intervention
Are the benefits greater than those for participation in traditional balance training exercises
Do the benefits vary with the severity of disability

Participants will receive either EMG Biofeedback EMG-BF training or traditional balance exercise BAL-EX training Both treatments involve three 30-minute sessions of the training every week for 6 weeks 18 sessions During the sessions participants in the EMG-BF treatment group will perform targeted exercises using feedback from adhesive sticker sensors on their arms and legs Participants in the BAL-EX treatment group will following an instructor through balance training movements that are traditionally prescribed by physiotherapists to improve balance Measurements will be taken at the beginning of the study after six weeks of training and three months after the end of training

Researchers will compare the groups to see if balance and related outcomes are improved more by 6-weeks of EMG-BF training than BAL-EX
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None